Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase-treated tumor cells
- 15 January 1974
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 13 (1), 71-81
- https://doi.org/10.1002/ijc.2910130109
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Immunospecific Regression of Methylcholanthrene Fibrosarcoma Using NeuraminidaseAnnals of Surgery, 1972
- SIALIC ACIDS ON THE PLASMA MEMBRANE OF CULTURED HUMAN LYMPHOID CELLSThe Journal of cell biology, 1972
- Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCGScience, 1971
- Failure of Neuraminidase to Unmask Allogeneic Antigens on Cell SurfacesExperimental Biology and Medicine, 1971
- Further Studies on the Effect of Neuraminidase on Tumor Cell TransplantabilityTissue Antigens, 1971
- ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLSThe Journal of Experimental Medicine, 1971
- Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.British Journal of Cancer, 1969
- THE EFFECT OF NEURAMINIDASE ON THE FATE OF TRANSFUSED LYMPHOCYTESThe Journal of Experimental Medicine, 1969
- The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumourBritish Journal of Cancer, 1968
- Immunogenicity of L 1210 Murine Leukaemia Cells after Treatment with NeuraminidaseNature, 1968